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1. Introduction  
1.1 Overview on pneumoconioses 
Pneumoconiosis is an occupational lung disease caused by the exposure to dust. This section 
summarizes the generalities on pneumoconioses, including definitions, epidemiology and 
clinical manifestations of those occupational and environmental lung diseases. The most 
important step in the diagnosis of pneumoconiosis in to question the subject regarding 
specifics of the actual job and the minerals or materials involved in case of history of dust 
exposure. It is very important to seek a detailed account of workers’ past employment, too; 
as some pneumoconioses develop after only a brief but intense dust exposure.  
 Lately, many cases have been linked to environmental exposure to dust. This suggests that 
pneumoconiosis is no more a pathology exclusively related to work. Clinicians and 
epidemiologists should keep in mind the fact that cigarette smoking has a devastating 
impact of the health of dust-exposed individuals. Rates of cigarette smoking as high as 80% 
have been recorded among miners and other dust-exposed populations (Baum et al, 1998; 
Hammond et al, 1979). Asbestos-related diseases, silicosis and coal worker’s 
pneumoconiosis (CWP) are most predominant and widely investigated pneumoconioses. 
Pneumoconioses have relatively specific radiologic features that are not well-known to most 
physicians. Radiological imaging plays an important role in the diagnosis of those 
occupational lung diseases, including asbestos-related diseases, Silicosis and coal worker’s 
pneumoconiosis (Ngatu et al, 2010; Blum et al, 2008). This review is aimed at providing 
health care workers, especially clinicians, with basic and accurate knowledge on principal 
radiologic features often found on a pneumoconiotic chest radiograph that characterize each 
of the above mentioned lung diseases related to occupational or environmental exposure to 
dust. 
1.2 Asbestosis and other asbestos-related diseases (ARDs) 
1.2.1 Definitions and epidemiology 
Asbestosis refers to the pneumoconiosis caused by inhalation of asbestos fibers. It is 
characterized by a slowly progressive, diffuse pulmonary fibrosis. Asbestos is a fibrous 
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mineral whose specific properties have encouraged its use since ancient times, in particular 
for industrial applications since the 19th century (Tarres et al, 2009; American Thoracic 
Society [ATS], 2001). Few natural materials used in industry have been the subject of more 
epidemiological and pathological research than the fibrous mineral, asbestos. Asbestos 
fibers are divided into two categories based on fiber’s shape:  
- serpentine fibers (curly, long strands) of which chrisotile (white asbestos) is the most 
commercialized;  it accounts for more than 90 percent of the asbestos produced in the 
United States;  
- amphibole fibers (long and straight) which include amosite (brown asbestos), tremolite,  
crocidolite and  other types of asbestos. 
Of the different asbestos fibers used in industries, crocidolite (blue asbestos) is generally 
considered to be less toxic. The amphibole and amosite are reported to carry the greater risk 
of causing other asbestos-related diseases such as pleural plaque, mesothelioma and lung 
cancer. Exposed workers who have developed asbestosis are at risk of fatal complications 
(Wagner, 1997; Sichletidis et al, 2009; Mossman et al, 1990). 
In patients with asbestosis, the chest radiograph usually shows small bilateral parenchymal 
opacities with a multinodular or reticular pattern that may be associated with pleural 
abnormalities. However, in some individuals with histopathologic evidence of pulmonary 
fibrosis, no interstitial abnormalities are found on the chest radiographs (Larson et al, 2010; 
Kipen et al, 1987). Other asbestos-related disorders are: pleural plaques, mesothelioma, 
diffuse pleural fibrosis, rounded atelectasia, benign asbestos-related pleural effusion and 
chronic bronchitis. In the course of asbestosis development, other radiographic features such 
as honeycombing changes and ground-glass opacities can be seen on the radiograph; they 
are well visualized on computed tomography (CT) and high resolution computed 
tomography (HRCT) scans. 
It is estimated that approximately 27 millions workers in the United States received a 
significant exposure to asbestos during the middle of the last four decades of the twentieth 
century.  
Pleural disease is one of the characteristics of asbestos exposure. Pleural plaques are present 
in about 50 percent of asbestos exposed individuals and most commonly involve the parietal 
pleura, while involvement of the visceral pleura is scarce. The histological examination of 
pleural plaque specimens shows the presence of predominant acellular bandles of collagen 
(Yang et al, 2010).        
The prevalence of both pleural plaques and asbestosis is associated with “time since the first 
exposure” (TSFE) to asbestos, the “exposure intensity level”, the “duration or cumulative 
exposure” to asbestos. Meanwhile, time since the first exposure seems to be the best predictor for 
pleural plaques related to asbestos exposure, whereas cumulative exposure to asbestos is 
reported to be a major determinant for asbestosis (American Thoracic Society [ATS], 2004; 
Schart, 1991). In a study conducted in Finish construction, shipyards and asbestos industry 
workers by Koskinen and coworkers (1998), a strong relationship was found between pleural 
plaques and time since the first exposure to asbestos. A recent study by Paris et al. (2009) showed 
for the first time, in a multivariate analysis, strong and independent correlations between time 
since first exposure and pleural plaques, and between cumulative or level of exposure with both 
pleural plaques and asbestosis, indicating that time and dose parameters should be included 
in the definition of high-risk populations in screening programs. 
Malignant mesothelioma is an aggressive tumor that develops from the mesothelial cell of the 






The association between malignant mesothelioma and asbestos exposure has been well-known 
worldwide since the 1950s. Approximately, 90% of malignant mesothelioma cases are related 
to ealier exposure to asbestos and the risk of developing the disease is greater in case of 
exposure to the amphibole fibers in crocidolite and amosite, but serpentine fibers in chrysotile 
can also cause the disease with a relatively long latency period (30 years or more) (Fujimoto et 
al, 2010; Snashall et al, 2001). In Japan, one of the biggest consumers of asbestos in the last four 
decades of the twentieth century, the number of cases of malignant mesothelioma is shown to 
correlate with the amount of asbestos consumption and the country has been expected to 
confront an epidemic of asbestos-related malignancy (Suganuma et al, 2001; Takahashi, 1999). 
 The incidence of malignant pleural mesothelioma, an asbestos-related tumor, is increasing, 
with a median survival of seven to ten months; its clinical pattern usually involves 
substantial pain and dyspnea. The disease causes approximately 15,000 to 20,000 deaths per 
year worldwide (Pass et al, 2008).  
Lung cancer can be consecutive to asbestos exposure. Clinician’s search during risk 
assessment in patients with possible dust exposure may be hindered by the long latency 
period between the inhalation and the appearance clinical manifestions. In addition to its 
fibrogenic properties, asbestos is a first-level carcinogen and the most accepted oncological 
model is the dose-response without safety level (Rosell-Murphy et al, 2010; Goldberg et al, 
1999). According to some previous studies, smoking increases the risk of lung cancer in 
asbestos exposed individuals by 50 – 90 times more than non-smokers (Valavanidis et al, 
1996; Hartly et al, 2000).  
A variety of occupational and nonoccupational settings can be source of exposure to 
asbestos: 
- Manufacture of asbestos products 
- Thermal and fire insulation 
- Construction and demolition work 
- Shipbuilding and repair 
- Building maintenance and repair 
- Plumbers and gasfitters 




Since a while, there is an increasing number of reports on cases of asbestos-related diseases 
in workers whose occupations have not been traditionally on the lists of occupational health 
specialists. Asbestosis and pleural plaques have been found in dentists and mechanics in 
Europe and the United States. And in some cases, these asbestos-related abnormalities are of 
unusual source of exposure.  
Torbica and Krstev (2006) suggested that asbestos-related diseases in dentists might be 
linked to exposure to inorganic dust in the manufacturing of cobalt-chromium- 
molybdenum- based dental protheses. With the use of white asbestos-made lining material 
for casting rings in dentistry, dental technicians and dentists are potentially exposed to 
asbestos; and some cases of pleural plaques and malignant mesothelioma have been 
reported in a number of dentists after a relatively long period of work (35 to 45 years) (Choel 
et al, 2001; Reid et al, 1991; Sichletidis et at, 2009; Radi et al, 2002). 
Similarly, pneumoconiosis may occur in mechanics. Most motor vehicles, from passenger 
cars to heavy duty trucks, have disc brakes on the front wheels and drum brakes on the rear 
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wheels which help control their movement. Asbestos containing brake lining is generally 
found in those vehicles, ranging from 35% to 65% of chrysotile contents. Their repair or 
replacement can be a source of exposure to asbestos (Gilles, 2005; Paustnebach et al, 2004; 
Kakooei et al, 2004).  
According to previously published reports, the incidence of lung cancer and malignant 
mesothelioma in auto mechanics is higher than in the general population. In the Unites 
States, concentrations of airborne asbestos more than 300 times higher than the current 
permissible exposure limit (Occupational Safety and Health Agency, OSHA) of 0.1 fiber/cc 
were found (Levin et al, 1999; Lorimer et al, 1976; Rohl et al, 1976). 
1.2.2 Clinical manifestations of asbestos-related diseases 
For asbestosis, in general, the latency period between exposure and the appearance of 
symptoms is inversely proportional to the intensity of asbestos exposure. And the majority 
of patients remain asymptomatic for 20- 30 years after the first exposure, even though 
pleural plaque is present. The first symptom of asbestosis to appear is usually breathlessness 
with exertion. Dyspnea will follow as the disease progresses; however, cough, wheezing, 
sputum production are often present when the patient has a history of cigarette smoking. 
With the progression of the disease, the patient will develop bibasilar crackles heard mostly 
at the end of inspiration, and clubbing. Pleural disease occurs earlier mostly within 15 years 
since the initial exposure to asbestos (Epler et al, 1982; Paris et al, 2009). 
1.3 Silicosis 
1.3.1 Definition and epidemiology 
Silicosis is an interstitial pulmonary disease secondary to the inhalation of crystalline silica 
(silicon dioxide), usually in the form of quartz, and less commonly as cristobalite and 
tridymite. It is one of the world’s oldest known occupational diseases characterized by 
irreversible, progressive lung disease. Crystalline silica has long been considered as the toxic 
form of silica; however, very little was known about the toxicity of amorphous silica until 
the very recent toxicological and mechanistic study in animals by Constantini and cowokers 
that revealed the fact that both crystalline and amorphous (which has been regarded as non-
fibrogenic) silica are phagocytosed and are both toxic to alveolar macrophages and have 
similar pathway that lead to apoptosis. 
Silica, the second most abundant element that forms the quarter part of the earth’s crust, is 
an ubiquitous mineral in human environment. Thus, exposure to silicon dioxide and salts of 
silicic acid is a fact of life. However, intense exposure can lead to silicosis (Pascual et al, 
2011; Wagner, 1995; Constantini et al, 2011; Baum et al, 1998). Silica is also bound to other 
minerals; it is then called silicate. Silicates are used in some industries; they include asbestos, 
talc (Mg3S4O10 (OH)2), and kaoline (Al2Si2O5(OH)4) [Gamble, 1986]. 
New cases of Silicosis are annually recognized worldwide.  In the United States, up to 
200,000 miners and 1.7 million non-mining workers have experienced significant 
occupational exposure to inhaled silica; and every year the country register between 3600 
and 7300 new cases of Silicosis. The overall mortality attributable to Silicosis has decreased 
in the United states  thanks to the improvement of workplace protection, compared to that 
of 30 years ago (3000 deaths a year) [Rosenman et al, 2003; CDC, 2008; NIOSH, 1999]. 
Silicosis can occur in many industries and work settings with evident dust exposure such as: 







 Construction work, masonry. 
 Sandblasting 
 Foundry work 
 Ceramics, etc. 
The list is not complete; there are numerous other work sites with silica exposure, as free 
silica can be found anywhere. Mining and construction work that involve drilling, cutting, 
grinding or crushing the earth’s crust or rocks are associated with high level of silica 
exposure. In several developing countries, in Africa and Asia particularly, mining and 
minerals processing industries represent the main source of income. It is common to find 
employers who fail to provide necessary personal protective materials to workers, putting 
them at high risk of occupational lung disease such as silicosis.  
It is also obvious that, in some occupational settings, workers may be exposed to both silica 
and asbestos or other dust and develop what is called a mixed-dust pneumoconiosis (MDP). 
MDP is pathologically defined as an occupational lung disease that shows dust macules or 
mixed-dust fibrotic nodules, with or without silicotic nodules, in an individual with a history 
of exposure to mixed dust [Honma et al, 2004]. Radiologic features of MDP may include those 
related to exposure to silica and other fibrogenic duts such as silicates, metals, carbon.  
1.3.2 Clinical manifestations of Silicosis 
Clinical forms of Silicosis are described according to both their clinical and radiological 
manifestations. They are divided into: 
 Simple Silicosis 
 Acute Silicosis 
 Chronic silicosis 
 Accelerated silicosis 
Simple Silicosis is characterized by the presence of small (less than 10 mm in diameter) opacities 
that are rounded in general, on the chest radiograph, and mostly without symptoms. 
Acute Silicosis often occurs after weeks or a few years of an intense exposure to silica. The 
presence of silicotic nodules on the chest radiograph or computed tomography scan is the 
main radiologic manifestation. 
Chronic silicosis usually appears 10 – 30 years after the initial exposure to silica and develops 
slowly. This clinical form often share the same radiographic feature with simple Silicosis; 
but in some cases silicotic nodules may coalesce and form a large opacity which represent a 
progressive massive fibrosis (PMF). Both accelerated and chronic silicosis have similar 
radiographic features. The only trait that differentiates them is the interval between the 
exposure to silica dust and the development of the disease symptoms.  
Accelerated Silicosis occurs within ten years after initial exposure and is associated to high-
level exposure to silica. Both chronic and accelerated Silicosis may be asymptomatic with the 
patient having only an abnormal chest radiograph consistent with Silicosis. However, 
symptomatic patients would present with a chronic cough and dyspnea on exertion. Later, 
symptoms will become severe with the worsening of the radiographic abnormalities. 
Crackles, rhonchi and or wheeze may be present in some patients.  
The presence of large opacity or progressive massive fibrosis is always accompanied by the 
aggravation of patient’s status and respiratory impairment. The presence of emphysema, air 
trapping on chest radiograph may be observed (Munakata et al, 1985). Progressive massive 
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fibrosis (PMF) occurs when small rounded opacities enlarge progressively and coalesce to 
generate larger opacities (more than 10 mm in diameter). PMF, when it is present, its 
location is either the upper or the middle zone of the lung. 
Malignancy represents one of the complications of Silicosis.  The international Agency for 
Research on Cancer (IARC) determined in 1997 that there was evidence of carcinogenicity of 
crystalline silica (Scarselli et al, 2011). The relationship between silica exposure and lung 
cancer risk have been demonstrated in several studies. More than ten cohort studies have 
shown a standardized mortality ratio (SMR) between 1.37 and 3.70, and few reports showed 
stronger associations with highest risks and excess mortality from lung cancer among 
silicotics (Scarselli et al, 2011; Lacasse et al, 2005; Erren et a, 2009;Pelucchi et al, 2006). 
This suggests that clinicians should keep in mind the relationship between a workplace with 
exposure to silica dust and the development of lung cancer. Ignoring this fact may 
mistakenly lead the clinician towards a wrong diagnosis of the patient’s condition. 
1.4 Coal worker’s pneumoconiosis (CWP)  
1.4.1 Definition and epidemiology 
Coal worker’s pneumoconiosis is defined as an occupational lung disease caused by the 
deposition of coal mine dust in the lung parenchyma and the reaction of tissues to its 
presence. Coal mining has been used as a source of fuel for hundreds of years, and it still 
remains a major industry in countries such as the United States, France, Germany, Australia, 
China, India and South Africa. 
Recent researches suggest changes in terms of the epidemiology and clinical features of 
pneumoconiosis among underground coal miners that are characterized by an increase in 
the severity and rapid disease progression. Factors such as over-exposure to silica dust in 
coal mines, the increase in coal production and increasing hours of work are thought to be 
responsible of the current high prevalence and increased severity of the coal worker’s 
pneumoconiosis (CDC, 2007; Laney, 2009; Antao, 2005). 
Laney and Attfield’s more recent work, conducted in the Unites States, demonstrated the role of 
size of mine as another factor that contribute to the high prevalence and fatality of disease 
observed the last decades.  In their study, workers from small mines had a greater risk of coal 
worker’s pneumoconiosis and progressive massive fibrosis than their large mines counterparts. 
Smaller mining operations often have limited capital to upgrade safety equipment, and 
dedicated safety and personnel are less likely to be available to workers. This influences the 
implementation of dust monitoring and control activities in the mines (Laney & Attfield, 2010].  
1.4.2 Clinical forms of CWP 
CWP comprises two clinical forms: the simple and complicated Coal worker’s 
pneumoconiosis. Generally, simple CWP is not associated with symptoms. It is often 
characterized by a history of underground exposure of more than 10 years. As for silicosis, 
the early radiological features are small rounded opacities that first appear on upper lobes 
of the lung. 
In contrast, complicated CWP is associated with symptoms and a marked impairment of lung 
function. Shortness of breath, cough and sputum production are common symptoms (Caplan, 
1953). The pattern and severity of respiratory impairment in coal worker’s pneumoconiosis are 
related to the levels of coal mine dust exposure, geologic factors, exposure to other respiratory 






2. Classification of High Resolution Computed Tomography (HRCT) scans 
and chest radiographs of pneumoconioses  
2.1 Overview on the classification of pneumoconiotic HRCT scans 
The use of Computed Tomography (CT) has revolutionized the radiologic diagnosis of chest 
diseases as compared with conventional radiography. However, the ability of CT scanners to 
evaluate pulmonary parenchymal abnormalities is limited because of their resolving power. 
With the introduction of High-Resolution Computed Tomography (HRCT) techniques, it 
became possible to perform images of the lung with excellent spatial resolution, providing 
anatomic detail similar to that available from gross pathologic specimens (Kusaka et al., 2005). 
Thus, HRCT increases the specificity in the diagnosis of lung diseases, including 
pneumoconioses. In addition, the early diagnosis of these chronic diseases allows an early care 
and avoidance of further exposure to the hazardous dusts. For that reason, the proposed 
International Classification of HRCT of pneumoconiosis is used in some developed countries 
(such as Japan, Germany and Finland) in the screening and surveillance programs; however, 
its acceptance by international health institutions might take a time. 
The chest radiograph, which is easily accessible and cheaper, presently remains the unique 
internationally accepted diagnostic tool for pneumoconiosis. For this practical reason, in this 
chapter, we only present different parameters that are taken into account in the international 
classification of HRCT of pneumoconiosis. 
This section summarizes briefly the information on the proposed international classification 
of HRCT of pneumoconiosis. Though it is not yet accepted by the International Labor Office 
(ILO), clinicians should have in mind the existence of this tool which, sooner or later could 
be of use worldwide.  
The purpose of the international HRCT classification is to describe and code parenchymal 
and pleural manifestations of diffuse non-malignant occupational and environmental 
respiratory diseases. It is used for the screening (for early detection of pneumoconiosis) and 
surveillance and follow-up of the exposed individuals) (Kusaka et al., 2005).  
In asbestosis, the most common HRCT findings are centrilobular nodules on branching areas 
of high attenuation, and the thickened interlobular and intralobular lines, subpleural dot-like 
or curvilinear opacities and honeycombing predominantly distributed in the bases of the 
lungs. The interstitial fibrosis may also be manifested as traction bronchiectasis, honeycombing. 
On the other hand, in case of silicosis or CWP, the common characteristic radiologic features 
on HRCT scan are small opacities predominantly distributed in the upper zones of the lung 
and, sometimes, images of progressive massive fibrosis (large opacity) (Aberle et al., 1988; 
Akira et al., 2002).                                                           
The reading sheet used in the coding system for CT or HRCT films of pneumoconiosis has 
the following main parameters to be reported: film quality, parenchymal abnormalities 
(small opacities, large opacity, emphysema, honeycombing, inhomogenous attenuation of 
lung parenchyma, pleural abnormalities) ( Kusaka et al., 2005). 
- quality of the film:  four grades are considered, similarly to the ILO/ICRP (grade 1, 2, 3, 4; 
see ILO/ICRP). 
- parenchymal abnormalities: the absence (No) or presence (Yes) of small opacities (rounded 
or irregular) has to be reported on the reading sheet; their overall distribution is 
recorded in a grading system for each side (right, left), according to each zone of the 
thorax (upper [U], middle [M] or lower [L]). In addition, the severity of the disease is 
also reported as follows:  
0 = no definite opacities;  
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1=mild (present but only few small opacities);  
2=moderate (numerous small opacities);  
3=severe (very numerous small opacities and normal anatomical lung structure are poorly. 
A number of additional parenchymal abnormalities have to be checked:  
a. inhomogenous attenuation (absence [No] or presence [Yes] which may be due to the 
presence of ground glass opacities (GGO). When present on HRCT scan, the 
inhomogenous attenuation should be graded for each side and each zone for its extent 
as follows: 1=focal; 2=patchy; 3=diffuse. 
b. honeycombing (HC): absence (No) or presence (Yes);  
c. emphysema: absence (No) or presence (Yes) of emphysema has to be reported, and 
graded for right (R) and left (L) side, and for all zones as 1 (mild [up to 15% of area of 
one zone]), 2(moderate [15-30%]), 3(severe [more than 30%]). 
d. large opacity: absence (No) or presence (Yes). 
- pleural abnormalities: absence (No) or presence (Yes); two types of pleural abnormalities 
should be differentiated considering the CT appearance (parietal and visceral type). The 
parietal type refers to the flat thickening of the pleura, whereas the visceral type 
(diffuse pleural thickening) is associated with subpleural fibrosis or parenchymal bands 
(PB) and rounded atelectasis (RA). Their extent, width and location (medias- tinal, 
diaphragmatic,..) are also reported.  
- pleural calcifications: their absence (No) or presence (Yes) should also be reported on the 
reading sheet.  
Detailed information on the international classification of HRCT of pneumoconioses is 
available elsewhere (Kusaka et al., 2005). 
2.2 The ILO International Classification of chest Radiographs of Pneumoconiosis 
(ILO/ICRP) and ILO/WHO global program for the elimination of Silicosis (ILO/WHO 
GPES) 
The ILO 2000 International Classification of Radiographs of Pneumoconiosis (ILO/ ICRP) is 
used worldwide by experts to categorize conditions that are consistent with 
pneumoconiosis, with the use of a set of ILO standard films.  
This international classification system was created with the purpose of coding anterio-
posterior chest radiographs in a simple and reproducible manner; it provides a means for a 
systematic description and recording of radiographic abnormalities in the chest caused by 
the inhalation of dusts. It is useful in epidemiologic research, surveillance and medical 
checks of dust-exposed workers (Suganuma, 2001; International Labor Office [ILO], 2002). 
Chest radiographs of patients with silicosis, coal worker’s pneumoconiosis asbestosis and 
other asbestos-related diseases can be interpreted and classified the same way anywhere in 
the world using the ILO/ICRP system. In this section, basics on the principal radiologic 
features of pneumoconioses and their characteristics are summarized. In order to fully 
understand the system, a special training is of utmost importance. 
To classify a chest radiograph of a dust-exposed individual, there are four main points to be 
considered: 
- Technical quality; 
- presence (or absence) of parenchymal abnormalities consistent with pneumocoiosis; 
- presence (or absence) of pleural abnormalities 







Technical quality There are four grades:  
1. Good (grade 1);  
2. Acceptable, with no technical defect (grade 2); 
3. Acceptable, with some technical defect but still adequate for classification purposes 
(grade 3);  
4. Unacceptable for classification purposes (grade 4). 
A technical defect may be the presence of artifact, with poor contrast, under (light) or 
overexposed (dark) film or due to an improper position of the subject (overlapping of scapula, 
for example) or other defect. Artifacts can be interpreted as pathological abnormalities in case 
they mimic opacities, while the overlap of scapula (Fig. 1) can easily be interpreted as in-
profile or face on plaque. An abnormal feature related to the lung parenchyma or pleura may 
be present on the chest radiograph, but hidden by the overlapping scapula. When a chest 
radiograph is qualified as unreadable, it is necessary that another one be indicated. 
 
 
Fig. 1. Chest radiograph of poor quality showing overlapping scapula (white arrows) 
looking like pleural plaques on both right and left lung fields. 
[Courtesy of Prof. Dr. Yukinori Kusaka, Asian Intensive Reading of Pneumoconiosis radiographs 
(AIR PNEUMO)] 
2.2.1 Parenchymal abnormalities 
They include two types of opacities: small and large opacities. 
Small opacities are described by profusion, affected lung zones, the shape (rounded or 
irregular) and size.  
- Profusion refers to the concentration of small opacities in the affected zones of the lung; 
the are four categories of profusion (0, 1. 2, 3) and 12 sub-categories of profusion (0/-; 
0/0;  0/1; 1/1; 1/2; 2/1; 2/1; 2/2; 2/3; 3/2; 3/3; 3/+), where category 0 means the 
absence of small opacities or the presence of small opacities with a profusion lower than 
category 1, and category 3 has the highest profusion. 
To classify the dust-exposed individual’s chest radiograph, it has to be compared with the 
standard radiographs from ILO (known as ILO standard radiographs) which profusion 
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seems to be closer to that in the worker’s film. Standard radiographs provide examples of 
appearances classifiable as subcategory 0/0; 1/1; 2/2; 3/3.   
- Affected lung zone is the area the lung where small opacities are seen; each lung field is 
divided into three zones (upper, middle, lower) by horizontal lines. 
- Shape and size of small opacities are also recorded; for the shape, there are rounded and 
irregular (reticular) opacities. For small rounded opacities, there are three size ranges 
designated as p (diameter up to 1.5 mm), q (diameter exceeding 1.5 mm and up to 3 
mm), r (diameter exceeding 3mm and up to 10 mm). Similarly, for small irregular 
opacities, the three sizes are denoted by the letters s (opacities with a width up to 1.5 
mm), t (width exceeding 1.5mm and up to 3 mm), u (with a width exceeding 3mm and 
up to 10 mm). On each standard radiograph, the type of small opacities and their 
profusion are shown (for example: p/p, 2/2 which means ‘small opacities of p type and 
profusion 2/2). However, some chest radiographs may show both small rounded and 
irregular opacities; this often happens in case the worker was exposed to silica and 
asbestos, for example (mixed-dust pneumoconiosis). 
Large opacities are opacities whose longest diameter exceeds 10 mm. There are three 
categories of large opacities:  
- category A: one large opacity with longest dimension up to 50 mm, or several large 
opacities with the sum of their longest dimension not exceeding about 50 mm; 
- category B: longest diameter exceeding 50 mm, but not exceeding the equivalent area of 
the right upper zone; or several large opacities with the sum of their longest dimensions 
not exceeding the equivalent of the right upper zone (Fig. 2); 
- category C: one large opacity which exceeds the equivalent area of the right upper zone, 






Fig. 2. Silicotic chest radiograph showing a large opacity of category B (black arrows) on the right 
upper zone. Numerous rounded opacities (q type) are present in all zones of the lung field. 







Fig. 3. Chest radiograph showing calcified diaphragmatic pleural plaques (white arrows) 
and face-on plaques (blue arrows) bilaterally. In this film, pleural plaques can also be seen in 
other site (mediastinal region bilaterally). 
(Courtesy of Prof. Dr Yukinori Kusaka, AIR PNEUMO) 
 
 
Fig. 4. Chest radiograph showing an in-profile pleural plaque (arrows) in asbestos-exposed 
worker. 
(Courtesy of Dr Hisao Shida) 
2.2.2 Pleural abnormalities 
They comprise pleural plaques (localized pleural thickening), costophrenic angle obliteration and 
diffuse pleural thickening (DPT). 
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Pleural plaques may be located on the diaphragm, on the chest wall (in-profile or face-on 
plaques) and at other sites; they generally represent a thickening of the parietal pleura and 
are recoded as present or absent. 
Other details regarding the site (right or left lung), presence or absence of calcification, 
width and extent of the plaque are recorded. 
2.2.3 Costophrenic angle obliteration and diffuse pleural thickening 
Costophrenic angle obliteration is recoded as present or absent. However, with the ILO 
classification, diffuse pleural thickening extending up to the lateral chest wall is recorded only 
in case of an obliterated costophrenic angle. All details are summarized in a single chest 
radiograph reading sheet (ILO, 2002). 
The global program for the elimination of Silicosis (GPES) was adopted in 2003, Geneva, by 
a panel of experts in occupational health. It is aimed at establishing a wide international co-
operation so as to eliminate Silicosis by the year 2030 (World Health Organization [WHO], 
2003). GPES was established following recommendations of the twelfth session of the joint 
ILO/WHO Committee on occupational health in 1995, which indentified the global 
elimination of silicosis as a priority area for action in occupational health. The committee 
wanted countries to place it high on their agendas, with the belief that the experience gained 
through implementation of this program would provide a prevention model for other 
pneumoconioses and a proven system for the management of exposure to mineral dust. 
The GEPS has two different approaches; the primary prevention of Silicosis that emphasizes 
the control of silica hazard at source using engineered methods of dust control, while the 
secondary prevention includes surveillance of the work environment to assess the efficacy of 
the implemented measures for dust exposure control, exposure evaluation by assessing health 
risk for workers and surveillance of workers’ health for the early diagnosis of the disease.  
In most industrialized countries, following recommendation of the ILO/WHO Global 
Program for the Elimination of Silicosis, pneumoconiosis prevention programs have been 
initiated to protect workers from dust exposure and the actual trend of show a decrease in 
number of new cases. On the other hand, in the majority of developing countries millions of 
workers continue to be exposure to dust.  In order to reach the goal by 2030, each country 
should have its own national program. Unfortunately, the reality shows that there are still 
obstacles that might make it difficult to reach the GPES goal by 2030: one is the non 
adherence of some countries to the ILO/WHO program and, the insufficiency of qualified 
individuals in the interpretation of pneumoconiotic chest radiographs.  
Under the ILO/WHO GPES, experts focused manly on secondary prevention, upgrading 
skills of occupational physicians in developing countries in using the ILO 2000 Classification 
of Radiographs of Pneumoconiosis (ILO 2000 ICRP) and strengthening national Silicosis 
elimination programs (Luton, 2007).  
3. Short training on pneumoconiosis chest radiographs reading 
3.1 Objective 
The ILO classification system is an important tool for training occupational physicians in the 
diagnosis of pneumoconioses. Based on this ILO system, some countries have developed 
their own national program and produced necessary teaching materials. In the United 
States, the National Institute for Occupational Health (NIOSH) provides certification tests 






the B-readers system. And, since the year 2008, the Asian Intensive Reading of 
Pnemoconioses chest radiographs (AIR-PNEUMO) program started, organizing annual 
workshops and certification test for Asian countries and also Brazil. These programs 
contribute a lot for the achievement of the ILO/WHO Global Program for the Elimination of 
Silicosis, and also those dedicated to the elimination of asbestosis. 
However, the number of physicians who have required skills to interpret pneumoconiotic 
radiographs remains insignificant in many regions of the world, as participation to ILO 
training course by physicians is quite costly and, moreover, the absence of local trainers 
constitutes a real obstacle. Countries that do not yet get involved in the ILO/WHO program 
are numerous. Despite the existence of institution such Air-pneumo, NIOSH and others, the 
elimination of silicosis may not be achieved by the year 2030 without involvement of 
governments and health authorities of all nations. Providing basic knowledge on 
pneumoconiosis to clinicians and those who are about to graduate from medical school 
would also be helpful for the diagnosis of pneumoconiosis, particularly in regions where 
occupational or environmental exposure to dust represent a real public health issue. Here is 
presented a short training on pneumocnioses and the evaluation of its potential to improve 
physicians’ ability to detect main pneumoconiotic radiographic features on chest 
radiographs of dust-exposed individuals. 
3.2 Differentiating normal and pneumoconiotic radiographs 
Radiological imaging plays an important role in the diagnosis of pneumoconiosis. Although 
chest radiography has some limitations in terms of detecting earliest parenchymal and pleural 
abnormalities, it remains the most useful and universally accepted method for assessing 
pneumoconiosis; it is an easily accessible, cheap diagnostic tool (Takashima et al., 2007).  
On a normal chest radiograph (Fig. 5), there are anatomical structures that resemble 
abnormal features and may lead the reader to wrong interpretation. The presence of lymph   
 
 
Fig. 5. Normal chest radiograph showing normal anatomical features. Note the presence of 
opacities that represent lymph nodes and blood vessels. 
(Courtesy of Dr Hisao Shida) 
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Fig. 6. Silicotic chest radiograph showing small rounded opacities of q type mostly, with 
involvement of all lung zones (upper, middle and lower zones). Coalescence of small 
rounded opacities is seen on the right upper zone. 
(Courtesy of Dr Hisao Shida) 
nodes, muscles (serratus anterior, oblique externus abdominis...), pleural fat’s shadow and 
normal cross-section or tangential views of blood vessels can be interpreted as opacities or  
pleural plaques related to pneumoconiosis, for example. This poses a challenge during chest 
radiograph reading process and may lead to misclassification of conditions consistent with 
pneumoconioses (Ngatu et al, 2010; Jinkai et al, 2008).   
For individuals who present with pneumoconiotic-like radiographic features, establishing 
the history of dust exposure is an important step towards the confirmation of the diagnosis. 
A silicotic or coal worker’s pneumoconiosis’ chest radiograph will often present small 
rounded opacities (opacities having a diameter up to 10 mm) as parenchymal abnormalities 
(Fig. 6). When they coalesce, small opacities form a large opacity (having a diameter > 10 
mm). In addition, a silicotic radiograph may also show calcified lymph nodes (eggshell 
calcifications). In silicosis, small opacities are first localized on the upper zone of the lung, 
then will progress towards the middle and lower zones. 
In contrast, a chest radiograph from an asbestosis patient will often present small irregular 
opacities (opacities having a longest dimension up to 10 mm) as parenchymal abnormalities 
(Fig. 7) and/or pleural plaque (s). Asbestosis small opacities appear on the lower zone of the 
lung, then later progress towards the middle and the upper lung zones. Other features may 
also be present such as diffuse pleural thickening, honeycombing changes.  
The table below summarizes frequently found pneumoconiotic radiographic features for 
mineral dust-exposed subjects: their localization according to the type of pneumoconiosis, 
and their shape and size for small opacities (Table 1). It is important to know that 
individuals exposed to both silica and asbestos may develop a “Mixed Dust Pneumoconiosis 
(MDP); the radiograph may show a combination of features of silica, asbestos or other 







Fig. 7. Chest radiograph of asbestos-exposed worker showing the presence of small irregular 
opacities (of “t” type primarily and “s” type secondarily), predominantly on lower and 
middle lung zones. The right upper lobe is also involved. The profusion is 2/3. In addition, 
diffuse pleural thickening (DPT) is evident on the right and in-profile plaque on the left; also 
note the abnormal cardiac size. The film quality is of grade 2 (scapula overlap). 
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3.3 Implementation of the two-hour training session 
3.3.1 Participants and methods 
For the first reported training held in 2008, 102 Japanese physicians (72 males and 28 
females; 2 to 44 years of experience) having different background (preventive medicine, 
internal medicine, psychiatrists, surgery, pediatrics) from different cities within the country. 
Participants were invited to the 2008 training session held in Kochi and Ehime prefecture 
through the staff of Japanese medical corporations, and the training session was conducted 
by a NIOSH-B reader from Kochi University Medical School, Japan. 
We used three sets of chest radiographs were used, namely ILO/ICRP standard films, dust-
exposed workers’ chest radiographs and a set of twelve test films. ILO standard films were 
used to describe pneumoconiotic lung abnormalities (shape, size, profusion of small 
opacities; large opacities, pleural plaques) during the lecture. Dust-exposed workers’ chest 
radiographs, having different radiographic features of pneumoconioses, were provided by 
the Japan Pneumoconioses Study Group (JPSG). In order to read them, each film was put 
side by side with the ILO standard whose profusion, for example, seems to be close to that 
of the patient.  
Our intervention was aimed at improving inexperienced physicians’ skill in reading 
pneumo-coniotic chest radiographs. Participants had to listen to a pre-session talk to remind 
them the abnormalities to be checked on each of patients’ radiographs (before the main 
lecture); then, they take a pre-test as described in the protocol (Fig. 8). Each participant 
received a reading form that had a list of 12 radiograph numbers (from 1 to 12) and they had 
to check for the presence (Yes) or the absence (No) of parenchymal or pleural abnormalities 
consistent with pneumoconiosis (opacities and pleural plaques) for each chest radiograph. 
Classifying the radiographs using categories of profusion of small opacities, location, width 
or extent of pleural plaques was not indicated. The main lecture was given after the pre-test 
for two-hours; afterwards a post-test was organized using the same test films that were 



















reading skill befo re 




Fig. 8. Protocol of the intervention study  (CXR: chest radiograph; JPSG: Japan 
pneumoconiosis study group) 
3.3.2 Evaluation of physicians’ reading skill and observed results 
The reading forms were collected and managed by s staff who no relationship with any of 






(pre-test and post-test) results.   The difference in the physicians’ reading skill before and 
after the intervention was evaluated using McNemar’s chi-square test. 
The general trend was towards improvement in terms of physicians’ ability to detect 
pneumoconiotic parenchymal and pleural abnormalities on the test-radiographs. Regarding 
the dectection of the presence of pneumoconiotic small opacities, a significant increase in the 
specificity score  was observed, 65% in the pre-test and 73% in post-test (p<0.0001); whereas 
the sensitivity score remained high, 84% and 81% in pre- and post-test (p>0.05), respectively 
(Table 2). It is noticeable that the high sensitivity score in the pre-test was due to a high 
proportion of physicians who considered the normal radiographs to have pneumoconiotic 
opacities (false positive or over reading) in the pre-intervention test. The over reading of 
test radiographs was noticeable for the pre-intervention test for most of the readers. 
 
Lung abnormality  Sensitivity p Specificity p
pre-test            post-test pre-test     post-test
Small opacitity 84%                     81% 0.204 65%            73% <0.0001
Pleural plaque 46%                     60% <0.0001 77%            79% 0.3339
 
p: p-value by McNemar’s chi-square test. 
Table 2. Overall distribution of the sensitivity and specificity scores of the participants for 
detecting pneumoconiotic small opacities and pleural plaques on chest radiographs 
Group of readers Lung abnormality Sensitivity p Specificity p
pre-test   post-test pre-test   post-test
1. Internists Small opacity 83%          78% 0.208 67%           76% <0.01
Pleural plaque 41%          61% <0.0001 83%           80% 0.21
2. Other specialities Small opacity 85%          83% 0.546 63%           71% <0.01
Pleural plaque 50%          59% <0.05 72%           79% <0.05
 
p: p-value by McNemar’s chi-square test. 
Table 3. Distribution of sensitivity and specificity scores of readers for detecting 
pneumoconiotic abnormalities according to medical specialty. 
For pleural plaques, a marked increase in the sensitivity score was noted, 46% in pre-test 
and 60% in post-test (p<0.0001), while an improvement was also observed in the specificity 
score but not significantly (77% and 79% in pre and post-test, respectively) (p>0.05) as 
shown in Table 2. 
When compared according their medical specialties, a relatively similar reading skill 
improvement was observed between internists and physicians from working in other 
departments. Higher scores of sensitivity for the detection of small opacities and specificity 
for plaques were found in internists, and a similar trend was also noted in the group of 
physicians from other specialties in which a significant improvement of specificity score for 
pleural plaques was found (p<0.05) in the post-test (Table 3) (Ngatu et al, 2010). 
The lack of training for medical doctors in the diagnosis of occupational diseases is the main 
factor leading to the misdiagnosis of pneumoconiosis as either chronic bronchitis or 
www.intechopen.com
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pulmonary tuberculosis (Murlidhar et al, 2005). One of the strong points of this training 
program is that, despite being carried out in relatively short time, it results in a noticeable 
improvement of physicians’ ability to detect pneumoconiotic parenchymal and pleural 
abnormalities. Popularizing such program may contribute to the early diagnosis of 
pneumoconioses, improve their prognosis and give chances of survival for individuals with 
lung diseases related to dust exposure. 
4. Conclusion 
This review article provides basic knowledge on pneumoconioses and a practical approach 
that may help physcians to diagnose occupational lung disorders related to exposure to 
mineral dust. Meanwhile, a training with demonstrations on the pneumoconiotic chest 
radiograph reading process is of utmost importance. Holding regular short period training 
courses for physicians, and even medical students who are about to graduate, focusing on 
main radiolographic features of lung parenchymal and pleural abnormalities related to 
occupational or environmental exposure to dust, with the use of typical ILO standard films, 
will contribute to improving their skill in the diagnosis of pneumoconioses.  
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